Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 fail
Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 fail
本文は利用できません。元の情報源をご確認ください。
Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 fail